ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke

NCT00300196 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

311

Enrollment

INDUSTRY

Sponsor class

Stopped Futility

Conditions

Stroke
Cerebral Ischemia
Brain Infarction

Interventions

BIOLOGICAL: Ancrod (Viprinex)
DRUG: Placebo

Sponsor

Neurobiological Technologies